AccuMed (US) takes over Sensititre (UK):
This article was originally published in Clinica
Executive Summary
Laboratory diagnostic products company AccuMed (US) has purchased Sensititre (UK) and its US assets and operations from Radiometer (Denmark) for an undisclosed amount. Blood gas metre manufacturer Radiometer has wanted to leave the microbiology market for some time and has in the past said it hopes to end up with an extraordinary pre-tax income for the Sensititre operations of $1-2.5 million (see Clinica No 635, p 17). Sensititre produces antimicrobial susceptibility and bacterial identification testing systems based on its microplate technology. It will become part of AccuMed's Microbiology Division which will be headed by Tony DiFranco, formerly Sensititre's vice-president of US operations. AccuMed is a privately-held company in Chicago with annual sales in excess of $5 million.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.